Clinical Trial Update: Daratumumab in Primary Antiphospholipid Syndrome [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating daratumumab for primary antiphospholipid syndrome. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Autoimmune Disorders | Phase 1, Phase 2 | Status: RECRUITING